IP Library Granted Patent US 7,898,416
Granted Patent B2
US 7,898,416 · App. 11/617,920 · Granted Mar 1, 2011

Systems and methods for managing information relating to medical fluids and containers therefor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,898,416
App. No.
11/617,920
Granted
Mar 1, 2011
Kind
B2
Abstract

The present invention relates to management of information relating to medical fluids, containers therefore, and medical fluid administration devices for administering such medical fluids to patients. Data tags (e.g., RFID tags) are generally associated with containers of the invention and may be electromagnetically read from and/or written to using an electromagnetic device, for example, that may be associated with a medical fluid administration device of the invention.

Claims (25)

1. A radiopharmaceutical container containing a radiopharmaceutical having a radioactivity level and a half life, the container having an RF data tag attached thereto, the RF data tag being readable by electromagnetic signals and storing data relating to a time at which the radiopharmaceutical in the radiopharmaceutical container is to be injected.

2. The radiopharmaceutical container of claim 1 , wherein the RF data tag further comprises configuration information for a radiopharmaceutical administration device.

3. The radiopharmaceutical container of claim 1 , wherein the RF data tag further comprises at least one of a product promotion and an electronic coupon code for sales of further products.

4. The radiopharmaceutical container of claim 1 , wherein the RF data tag further comprises a use code for the radiopharmaceutical.

5. The radiopharmaceutical container of claim 1 , wherein the RF data tag comprises data indicative of an amount of the radiopharmaceutical in the radiopharmaceutical container.

6. The radiopharmaceutical container of claim 1 , wherein the RF data tag comprises data indicative of an identity of the radiopharmaceutical in the container.

7. The radiopharmaceutical container of claim 1 , wherein the RF data tag comprises data indicative of a radioactivity level of the radiopharmaceutical.

8. The radiopharmaceutical container of claim 1 , wherein the RF data tag comprises data indicative of manufacturing information for the radiopharmaceutical.

9. The radiopharmaceutical container of claim 4 , wherein the use code identifies whether the radiopharmaceutical container has previously been used in a radiopharmaceutical administration procedure.

10. The radiopharmaceutical container of claim 2 , wherein the RF data tag comprises one or more of: a code that is required by the administration device prior to use of the container, a software update for the administration device, and references to information.

11. The radiopharmaceutical container of claim 1 , wherein the radiopharmaceutical container comprises a syringe.

12. A radiopharmaceutical container containing a radiopharmaceutical having a radioactivity level and a half life, the container having an RF data tag attached thereto, the RF data tag being readable by electromagnetic signals and storing data related to the radioactivity level for the radiopharmaceutical in the radiopharmaceutical container.

13. The radiopharmaceutical container of claim 12 , wherein the data related to the radioactivity level for the radiopharmaceutical in the radiopharmaceutical container comprises a decay factor for the radiopharmaceutical.

14. The radiopharmaceutical container of claim 12 , wherein the data related to the radioactivity level for the radiopharmaceutical in the radiopharmaceutical container comprises a prescribed activity level at an injection time.

15. The radiopharmaceutical container of claim 12 , wherein the data related to the radioactivity level for the radiopharmaceutical in the radiopharmaceutical container comprises radioactivity level at a time other than an injection time.

16. The radiopharmaceutical container of claim 12 , wherein the RF data tag comprises data indicative of a time at which the radiopharmaceutical is assumed to be injected.

17. The radiopharmaceutical container of claim 12 , wherein the RF data tag comprises configuration information for a radiopharmaceutical administration device.

18. The radiopharmaceutical container of claim 17 , wherein the RF data tag comprises one or more of: a code that is required by the administration device prior to use of the radiopharmaceutical container, a software update for the radiopharmaceutical administration device, and references to information.

19. The radiopharmaceutical container of claim 12 , wherein the RF data tag comprises at least one of a product promotion and an electronic coupon code for sales of further products.

20. The radiopharmaceutical container of claim 12 , wherein the RF data tag comprises data indicative of an amount of the radiopharmaceutical in the radiopharmaceutical container.

21. The radiopharmaceutical container of claim 12 , wherein the RF data tag comprises data indicative of an identity of the radiopharmaceutical in the container.

22. The radiopharmaceutical container of claim 12 , wherein the RF data tag comprises data indicative of manufacturing information for the radiopharmaceutical.

23. The radiopharmaceutical container of claim 12 , wherein the RF data tag comprises data indicative of a use code for the radiopharmaceutical.

24. The radiopharmaceutical container of claim 23 , wherein the use code identifies whether the radiopharmaceutical container has previously been used in a radiopharmaceutical administration procedure.

25. The radiopharmaceutical container of claim 12 , wherein the radiopharmaceutical container comprises a syringe.

Assignments (2)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →
RELEASE OF SECURITY INTEREST Recorded Jan 31, 2017
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: MALLINCKRODT NUCLEAR MEDICINE LLC
Reel/Frame 041131/0213 →